SWM
PCRX icon

SeaCrest Wealth Management’s Pacira BioSciences PCRX Stock Holding History

SeaCrest Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$4K – 1457
2019
Q1 		$4K Hold
100
– – ﹤0.01% 1791
2018
Q4 		$4K Hold
100
– – ﹤0.01% 1768
2018
Q3 		$5K Buy
+100
New +$4.32K ﹤0.01% 1870

Other funds holding PCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SeaCrest Wealth Management's PCRX Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of Pacira BioSciences (PCRX) in Q2 2019, closing a stake of 100 shares — an estimated $4K sold.

SeaCrest Wealth Management first reported a position in PCRX in Q3 2018 and held it in 3 quarters. The position peaked at $5K in Q3 2018. 218 funds tracked by Wall St. Rank hold PCRX as of Q2 2019.

  • SeaCrest Wealth Management reported no remaining Pacira BioSciences position as of Q2 2019 after selling out during the quarter.
  • SeaCrest Wealth Management sold 100 Pacira BioSciences shares in Q2 2019, an estimated $4K.
  • SeaCrest Wealth Management first reported a position in Pacira BioSciences in Q3 2018 and held it in 3 quarters.
  • SeaCrest Wealth Management's Pacira BioSciences position peaked at $5K in Q3 2018.
  • 218 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.